Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
Clinical trial NCT04651400 · COMPLETED
Trial details
- NCT number
- NCT04651400
- Sponsor
- Octapharma
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-19
- Primary completion
- 2022-09-27
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.